NCT05603455

Effect of Bifidobacterium Adolescentis on Aging in Healthy Adults (45-65 Years)

Effect of Bifidobacterium Adolescentis on Aging in Healthy Adults (45-65 Years) - a Multicenter, Double-blind, Randomized, Controlled Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
• Sex: All
• Age: 45 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study will include middle-aged and elderly people aged 45-65 years to carry out the translational study of Bifidobacterium adolescentis, and design a double-blind, randomized controlled clinical trial according to strict inclusion/exclusion criteria, using aging-related functional indicators, intestinal flora, DNA methylation and other advanced aging characteristic examination methods to fully and accurately assess the effects and safety of Bifidobacterium adolescentis on aging, which has the advantages of strong safety, high practice and high credibility compared with previous clinical trial protocols, laying an important foundation for improving probiotic anti-aging and exploring the development of aging intervention programs suitable for the Chinese population.

Conditions

• Healthy Adults (45-65 Years)

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Bifidobacterium adolescentis	Supplement with Bifidobacterium adolescentis twice/day in morning and tonight for 6 months
DIETARY_SUPPLEMENT	Placebo	Placebo

Timeline

• Start date: 2024-01-01
• Primary completion: 2024-07-30
• Completion: 2024-12-31
• First posted: 2022-11-02
• Last updated: 2023-02-09

Locations

1 site across 1 country: China